Western Pacific Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94K Hold
80
﹤0.01% 173
2025
Q4
$4.07K Hold
80
﹤0.01% 160
2025
Q3
$4.44K Hold
80
﹤0.01% 170
2025
Q2
$5.52K Hold
80
0.01% 173
2025
Q1
$5.55K Hold
80
0.01% 172
2024
Q4
$6.88K Hold
80
0.01% 175
2024
Q3
$9.53K Hold
80
0.01% 208
2024
Q2
$11.4K Hold
80
0.01% 181
2024
Q1
$10.3K Hold
80
0.01% 189
2023
Q4
$8.28K Hold
80
0.01% 194
2023
Q3
$7.28K Hold
80
0.01% 199
2023
Q2
$6.47K Buy
80
+24
+43% +$1.96K ﹤0.01% 206
2023
Q1
$4.46K Hold
56
﹤0.01% 235
2022
Q4
$3.79K Hold
56
﹤0.01% 238
2022
Q3
$2K Hold
56
﹤0.01% 223
2022
Q2
$3K Hold
56
﹤0.01% 168
2022
Q1
$3K Hold
56
﹤0.01% 193
2021
Q4
$3K Buy
+56
New +$3.03K ﹤0.01% 195

Other funds holding NVO

Western Pacific Wealth Management's NVO Position: Q1 2026 in Review

Western Pacific Wealth Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 80 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Western Pacific Wealth Management first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $11.4K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Western Pacific Wealth Management held 80 shares of Novo Nordisk worth $2.94K as of Q1 2026.
  • Western Pacific Wealth Management left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Western Pacific Wealth Management's portfolio in Q1 2026, its #173 holding.
  • Western Pacific Wealth Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • Western Pacific Wealth Management's Novo Nordisk position peaked at $11.4K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Western Pacific Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.